Raymond James Financial Inc. Buys Shares of 12,296 Trupanion, Inc. (NASDAQ:TRUP)

Raymond James Financial Inc. purchased a new position in shares of Trupanion, Inc. (NASDAQ:TRUPFree Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 12,296 shares of the financial services provider’s stock, valued at approximately $593,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. FMR LLC boosted its position in Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the last quarter. Baillie Gifford & Co. lifted its stake in shares of Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after purchasing an additional 147,341 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Trupanion by 4.4% during the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock worth $142,475,000 after purchasing an additional 142,156 shares during the last quarter. Hosking Partners LLP grew its position in shares of Trupanion by 52.5% in the fourth quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider’s stock valued at $10,253,000 after purchasing an additional 73,203 shares during the period. Finally, Barclays PLC increased its stake in Trupanion by 259.2% in the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock valued at $2,750,000 after purchasing an additional 47,262 shares during the last quarter.

Insider Activity

In other Trupanion news, SVP Emily Dreyer sold 14,025 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the transaction, the senior vice president now owns 27,645 shares in the company, valued at $895,974.45. This represents a 33.66 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Margaret Tooth sold 2,294 shares of the stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total transaction of $72,008.66. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at $3,728,629.76. This trade represents a 1.89 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 29,792 shares of company stock valued at $989,442. Company insiders own 5.50% of the company’s stock.

Analysts Set New Price Targets

TRUP has been the topic of a number of research analyst reports. Piper Sandler decreased their price target on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Stifel Nicolaus decreased their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.

View Our Latest Report on Trupanion

Trupanion Stock Performance

Shares of NASDAQ:TRUP opened at $34.34 on Monday. The firm has a market capitalization of $1.46 billion, a PE ratio of -149.30, a P/E/G ratio of 6.02 and a beta of 1.66. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The business has a 50-day moving average of $39.64 and a two-hundred day moving average of $46.20.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The business had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. As a group, research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

About Trupanion

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

See Also

Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUPFree Report).

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.